Persistent Rash with Chronic HCV Infection, Resoluting with Inteferon Treatment

ntroduction. Persistant erythema multiforme is a rare form of erythema multiforme with subacute typical and atypical lesions that occur during several months. Some cases are associated with chronic viral infection. Case report. A 23 year -old man, with a past history of intraveinous drug addiction and chronic hepatitis C virus infection, presented persistant erythema multiforme for 18 months. The histopathological picture was those of infectious erythema multiforme and the seric total complement level was low. Two courses of alpha-interferon treatment were quickly efficient on cutaneous lesions, and relapse occured after discontinuation. Discussion. In previously reported cases of persistant erythema multiforme, etiologic complementary investigations are not always specified. However, viral infections should be considered. In cases of chronic infection, hepatitis C may induce immune disorders through persistent antigenic stimulation.

Author: H PERROT, HOP ANTIQUAILLE, DERMATOL SERV, 1 RUE ANTIQUAILLE, F-69321 LYON 05, FRANCE; Source: ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 1997 APR;124(4):329-331

Hepatitis C Primer Home

What is Hepatitis How is Hepatitis Transmitted

Long-term Prognosis

Complications of HCV Liver Biopsy Treatment Info (Interferon, Herbal, etc) Lab Tests (PCR, Genotype,etc.) Nutrition & Alternative Info

Newsletter

Patient Information (Support Groups, Doctor Listing, etc) Related Webpages Transplant Info Site Search HCV Webrings Guestbook FAQ & Disclaimers

News and Updates

What You Should Know About Acupuncture for Hepatitis C
Learn the facts about how acupuncture can help chronic Hepatitis C - and what feats are beyond its reach.

Milk Thistle Interferes With Hepatitis C Replication
New evidence implies that milk thistle interrupts the Hepatitis C virus' reproduction and proliferation cycles.

Fast Track Granted to HCV Drug PSI-7977
Combining antiviral activity with a barrier to resistance, Pharmasset Inc.'s Hepatitis C drug, PSI-7977, has received fast track status by the FDA.